Effect of Bezafibrate Treatment Over Five Years on Coronary Plaques Causing 20% to 50% Diameter Narrowing (The Bezafibrate Coronary Atherosclerosis Intervention Trial [BECAIT])
- 1 November 1997
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 80 (9) , 1125-1129
- https://doi.org/10.1016/s0002-9149(97)00626-7
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Intermediate-Density Lipoproteins and Progression of Carotid Arterial Wall Intima-Media ThicknessCirculation, 1997
- The Role of Triglyceride-Rich Lipoprotein Families in the Progression of Atherosclerotic Lesions as Determined by Sequential Coronary Angiography From a Controlled Clinical TrialArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Lipoprotein Subclasses in the Monitored Atherosclerosis Regression Study (MARS)Arteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Coronary Plaque DisruptionCirculation, 1995
- Triglyceride-rich lipoproteins and the progression of coronary artery diseaseCurrent Opinion in Lipidology, 1995
- Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)The Lancet, 1994
- Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin.Circulation, 1994
- Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events.Circulation, 1993
- INTERMEDIATE-DENSITY LIPOPROTEINS AND PROGRESSION OF CORONARY ARTERY DISEASE IN HYPERCHOLESTEROLAEMIC MENThe Lancet, 1987
- Testing Statistical HypothesesPublished by Springer Nature ,1986